cefuroxime has been researched along with Urinary Tract Infections in 93 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Excerpt | Relevance | Reference |
---|---|---|
"Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily)." | 9.06 | Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up. ( Brumfitt, W; Hamilton-Miller, JM; Smith, GW, 1987) |
"Eighty-nine college women with acute urinary tract infections were treated orally with either 1,000 mg of cefuroxime axetil in a single dose (n = 59) or 250 mg of cefaclor three times a day for 7 days (n = 30)." | 9.06 | Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections. ( Iravani, A; Richard, GA, 1989) |
"In a prospective, randomized study, 58 men with complicated urinary tract infections were divided into two groups and treated intramuscularly with either cefuroxime (0." | 9.05 | Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study. ( Iversen, P; Madsen, PO, 1981) |
" The objectives of this study were to assess the clinical efficacy of intravenous cefuroxime as an empirical antibiotic for the treatment of hospitalized women with acute pyelonephritis (APN) caused by Escherichia coli." | 7.83 | Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. ( Chang, UI; Kim, HW; Wie, SH, 2016) |
"Cefuroxime axetil in a single daily dose of 250 mg for ten days was given to 75 women with symptoms of acute uncomplicated urinary tract infections." | 7.67 | Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil. ( Harris, K; Joy, GE; Leigh, DA; Tait, S; Walsh, B, 1989) |
"Cefuroxime axetil is an effective antimicrobial for uncomplicated pediatric UTIs." | 6.67 | Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children. ( Collins, JJ; Feld, LG; Kornberg, AE; Mydlow, PK; Sherin, K; Veiga, P, 1994) |
" Two hundred twenty-one patients aged 3 months to 7 years with febrile UTIs (defined as a combination of fever and leucocyturia in urine sediment) will be randomly assigned to a 7-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded placebo) or a 10-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded cefuroxime axetil)." | 5.27 | 7-day compared with 10-day antibiotic treatment for febrile urinary tract infections in children: protocol of a randomised controlled trial. ( Daniel, M; Pańczyk-Tomaszewska, M; Szajewska, H, 2018) |
"To compare the efficacy of fosfomycin trometamol, cefuroxime axetil, and amoxicillin clavulanate antibiotics, and to assess the difference in patient compliance, in the treatment of urinary tract infections during pregnancy." | 5.15 | Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy. ( Ates, U; Dogan, O; Kaya, E; Onar, Z; Usta, TA; Yucel, B, 2011) |
"Female patients presenting to their general practitioner with symptoms of uncomplicated urinary tract infection (cystitis) were entered into one of three therapeutic trials in a study programme of cefuroxime axetil (125 mg twice daily or 250 mg twice daily) conducted throughout the United Kingdom." | 5.07 | A large scale, general practice based investigation into the clinical efficacy and tolerability of cefuroxime axetil in women with uncomplicated urinary tract infection. ( Bulpitt, D; Jaderberg, M; Potter, CE, 1991) |
"Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily)." | 5.06 | Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up. ( Brumfitt, W; Hamilton-Miller, JM; Smith, GW, 1987) |
"Eighty-nine college women with acute urinary tract infections were treated orally with either 1,000 mg of cefuroxime axetil in a single dose (n = 59) or 250 mg of cefaclor three times a day for 7 days (n = 30)." | 5.06 | Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections. ( Iravani, A; Richard, GA, 1989) |
"In a prospective, randomized study, 58 men with complicated urinary tract infections were divided into two groups and treated intramuscularly with either cefuroxime (0." | 5.05 | Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study. ( Iversen, P; Madsen, PO, 1981) |
" The objectives of this study were to assess the clinical efficacy of intravenous cefuroxime as an empirical antibiotic for the treatment of hospitalized women with acute pyelonephritis (APN) caused by Escherichia coli." | 3.83 | Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. ( Chang, UI; Kim, HW; Wie, SH, 2016) |
"Nitrofurantoin has been used for decades for the treatment of urinary tract infections (UTIs), but clinically significant resistance in Escherichia coli is uncommon." | 3.80 | An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. ( Adriaenssens, N; Coenen, S; Godycki-Cwirko, M; Goossens, H; Harbarth, S; Kowalczyk, A; Lammens, C; Malhotra-Kumar, S; Stewardson, A; Vervoort, J; Xavier, BB, 2014) |
"To assess the safety and efficacy of cefuroxime axetil in the treatment of infections during pregnancy." | 3.70 | Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil. ( Manka, W; Okrzeja, D; Solowiow, R, 2000) |
"Cefuroxime axetil in a single daily dose of 250 mg for ten days was given to 75 women with symptoms of acute uncomplicated urinary tract infections." | 3.67 | Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil. ( Harris, K; Joy, GE; Leigh, DA; Tait, S; Walsh, B, 1989) |
"Cefuroxime axetil, an orally absorbed pro-drug of cefuroxime was used to treat a mainly elderly group of patients with symptomatic urinary tract infections." | 3.67 | Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection. ( Adams, DH; Ball, AP; Farrell, ID; Fox, C; Wood, MJ, 1985) |
"Cefuroxime (CXM) was administered to 11 patients with pediatric bacterial infections, and clinical effective results were obtained in all these cases." | 3.66 | [Clinical experience with cefuroxime in pediatric field (author's transl)]. ( Fujii, R; Komaki, K; Masuko, J; Matsueda, Y, 1979) |
"Also for lower respiratory tract infections (LTRI) the clinical and bacteriological responses were quite similar, although relatively more failures occurred in CF treated patients with LRTI caused by pneumococci." | 2.67 | Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety. ( Andersen, BM; Bergan, T; Brubakk, O; Bruun, JN; Døskeland, B; Hellum, KB; Hopen, G; Kalager, T; Rahm, V; von der Lippe, E, 1992) |
"After a follow-up of 1 year, septic arthritis was diagnosed in 9/362 patients (2." | 2.67 | Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations. ( Muytjens, HL; Slooff, TJ; Theeuwes, A; van Horn, JR; Wymenga, AB, 1992) |
"Cefuroxime axetil is an effective antimicrobial for uncomplicated pediatric UTIs." | 2.67 | Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children. ( Collins, JJ; Feld, LG; Kornberg, AE; Mydlow, PK; Sherin, K; Veiga, P, 1994) |
"The incidence of wound infections and the duration of hospitalization were significantly reduced in patients undergoing vaginal hysterectomy with or without vaginal repair." | 2.67 | Single-dose prophylaxis in hysterectomies. An interim analysis. ( Boodt, PJ; Janknegt, R; Snijders, WP, 1990) |
"Cefuroxime was successful, metronidazole failed in the prevention of minor morbidity." | 2.67 | Vaginal hysterectomy: cefuroxime, metronidazole or both? ( Kauer, FM; Manson, WL; Wijma, J, 1990) |
"The incidence of post-operative wound infections and urinary tract infections were similar in both groups [wound infections in 1/75 versus 2/84 patients (NS), urinary tract infections 4/75 versus 3/84 patients (NS), respectively, in the 24-h group and single-dose group]." | 2.67 | Antibiotic prophylaxis in abdominal hysterectomy, with special reference to the duration of the prophylaxis. ( Eckenhausen, FW; Jonker, PL, 1990) |
"Cefuroxime axetil (CAE) is an acetoxyethyl ester prodrug of cefuroxime." | 2.66 | Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin. ( Brown, GW; Cox, DM; Hebblethwaite, EM; Plested, SJ; Williams, KJ, 1987) |
"Renal parenchymal malacoplakia is a rare cause of acute renal failure." | 2.42 | Renal parenchymal malacoplakia: a rare cause of ARF with a review of recent literature. ( Chan, KW; Kung, WH; Li, R; Tam, VK, 2003) |
"Cefuroxime has been recommended in the 2015 list of the US FDA list of drugs which can be used safely during pregnancy." | 1.43 | A Relook of Cefuroxime in Community Infections: An Option Still Beneficial. ( Badhwar, VR; Ganapathy, S; Prabhudesai, PP; Tulara, NK; Varaiya, AY; Vyas, D, 2016) |
"Levofloxacin resistance was linked to mutations in gyrA and parC genes." | 1.42 | Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections. ( Biscaro, V; Caruso, A; De Francesco, MA; Gargiulo, F; Piccinelli, G, 2015) |
"Cefuroxime was a better predictor of cefpodoxime susceptibility than cephalothin, and appears to be the preferred surrogate agent for the MicroScan system, particularly for E." | 1.40 | Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates. ( Bland, CM; Bookstaver, DA; Mansell, KB; Woodberry, MW, 2014) |
"Cefuroxime seems to be a better candidate as first line therapy, however no clinical study supports its use." | 1.36 | [Empirical antibiotic therapy for urinary tract infection in children. Analysis of three hundred patients admitted to a general hospital]. ( Lefebvre, C; Lombet, J, 2010) |
" Urine samples were taken every 2 h during the whole dosing interval of the particular antibiotic." | 1.33 | Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model. ( Bedenic, B; Bubonja, M; Budimir, A; Topic, M, 2006) |
"2 h with a mean peak concentration of 8." | 1.28 | The pharmacokinetics of cefuroxime axetil in the sick elderly patient. ( Bielawska, C; Kelsey, MC; Rai, G; Ridgway, E; Stewart, K, 1991) |
" The concentration of drug in serum and urine was measured during treatment, and pharmacokinetic parameters were evaluated on the second and last days; the parameters obtained on the 2 days did not differ significantly." | 1.27 | Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. ( Berg, KJ; Nilsen, OG; Walstad, RA, 1983) |
"Aztreonam was active against Pseudomonas spp." | 1.27 | In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection. ( Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Webb, G, 1987) |
"None of the patients developed postoperative wound infections or adverse reactions." | 1.26 | Cefuroxime and metronidazole in gynaecological surgery. ( Kingston, J; Leabeater, B, 1981) |
"Cefuroxime (CXM) was administered for 1 week to spinal cord injury patients with chronic complicated urinary tract infection and the transitional change of micro-organisms was observed." | 1.26 | [Clinico-antimicrobial evaluation of cefuroxime by observation of transitional change of micro-organisms in urine specimen (author's transl)]. ( Tsujimoto, T; Yama, H; Yamada, K, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (34.41) | 18.7374 |
1990's | 27 (29.03) | 18.2507 |
2000's | 9 (9.68) | 29.6817 |
2010's | 18 (19.35) | 24.3611 |
2020's | 7 (7.53) | 2.80 |
Authors | Studies |
---|---|
Kasew, D | 1 |
Desalegn, B | 1 |
Aynalem, M | 1 |
Tila, S | 1 |
Diriba, D | 1 |
Afework, B | 1 |
Getie, M | 1 |
Biset, S | 1 |
Baynes, HW | 1 |
Jacewicz, M | 1 |
Günzel, K | 1 |
Rud, E | 1 |
Sandbæk, G | 1 |
Magheli, A | 1 |
Busch, J | 1 |
Hinz, S | 1 |
Baco, E | 1 |
Davis, WH | 1 |
Magee, MR | 1 |
Monks, SM | 1 |
Geno, KA | 1 |
Crawford, SB | 1 |
Owusu, H | 1 |
Thekkur, P | 1 |
Ashubwe-Jalemba, J | 1 |
Hedidor, GK | 1 |
Corquaye, O | 1 |
Aggor, A | 1 |
Steele-Dadzie, A | 1 |
Ankrah, D | 1 |
Mussema, A | 1 |
Admasu, D | 1 |
Bawore, S | 1 |
Abdo, R | 1 |
Seid, A | 1 |
Demirci-Duarte, S | 1 |
Unalan-Altintop, T | 1 |
Eser, OK | 1 |
Cakar, A | 1 |
Altun, B | 1 |
Sancak, B | 1 |
Gur, D | 1 |
Cusumano, JA | 1 |
Hermenau, M | 1 |
Gaitanis, M | 1 |
Travis, M | 1 |
LaPlante, KL | 1 |
Tran, TY | 1 |
McConeghy, KW | 1 |
Gökçe, İ | 1 |
Çiçek, N | 1 |
Güven, S | 1 |
Altuntaş, Ü | 1 |
Bıyıklı, N | 1 |
Yıldız, N | 1 |
Alpay, H | 1 |
Bosch-Nicolau, P | 1 |
Falcó, V | 1 |
Viñado, B | 1 |
Andreu, A | 1 |
Len, O | 1 |
Almirante, B | 1 |
Pigrau, C | 1 |
Daniel, M | 1 |
Szajewska, H | 1 |
Pańczyk-Tomaszewska, M | 1 |
Kõljalg, S | 1 |
Truusalu, K | 1 |
Stsepetova, J | 1 |
Pai, K | 1 |
Vainumäe, I | 1 |
Sepp, E | 1 |
Mikelsaar, M | 1 |
Bookstaver, DA | 1 |
Bland, CM | 1 |
Woodberry, MW | 1 |
Mansell, KB | 1 |
Vervoort, J | 1 |
Xavier, BB | 1 |
Stewardson, A | 1 |
Coenen, S | 1 |
Godycki-Cwirko, M | 1 |
Adriaenssens, N | 1 |
Kowalczyk, A | 1 |
Lammens, C | 1 |
Harbarth, S | 1 |
Goossens, H | 1 |
Malhotra-Kumar, S | 1 |
Can, F | 1 |
Azap, OK | 1 |
Seref, C | 1 |
Ispir, P | 1 |
Arslan, H | 1 |
Ergonul, O | 1 |
Sakran, W | 1 |
Smolkin, V | 1 |
Odetalla, A | 1 |
Halevy, R | 1 |
Koren, A | 1 |
Piccinelli, G | 1 |
Biscaro, V | 1 |
Gargiulo, F | 1 |
Caruso, A | 1 |
De Francesco, MA | 1 |
Süzük, S | 1 |
Kaşkatepe, B | 1 |
Avcıküçük, H | 1 |
Aksaray, S | 1 |
Başustaoğlu, A | 1 |
Chang, UI | 1 |
Kim, HW | 1 |
Wie, SH | 1 |
Ristola, MT | 1 |
Löyttyniemi, E | 1 |
Hurme, T | 1 |
Tziomalos, K | 1 |
Ntaios, G | 1 |
Miyakis, S | 1 |
Papanas, N | 1 |
Xanthis, A | 1 |
Agapakis, D | 1 |
Milionis, H | 1 |
Savopoulos, C | 1 |
Maltezos, E | 1 |
Hatzitolios, AI | 1 |
Badhwar, VR | 1 |
Ganapathy, S | 1 |
Prabhudesai, PP | 1 |
Tulara, NK | 1 |
Varaiya, AY | 1 |
Vyas, D | 1 |
Narchi, H | 1 |
Al-Hamdani, M | 1 |
Grgurević, I | 1 |
Pejsa, V | 1 |
Morović-Vergles, J | 1 |
Dobrić, I | 1 |
Gasparović, V | 1 |
Tudorić, N | 1 |
Biteker, M | 1 |
Duran, NE | 1 |
Biteker, FS | 1 |
Gündüz, S | 1 |
Gökdeniz, T | 1 |
Kaya, H | 1 |
Astarcioğlu, MA | 1 |
Ozkan, M | 1 |
van Iersel, M | 1 |
Mattijssen, V | 1 |
Lefebvre, C | 1 |
Lombet, J | 1 |
Vazquez, JC | 1 |
Abalos, E | 1 |
Usta, TA | 1 |
Dogan, O | 1 |
Ates, U | 1 |
Yucel, B | 1 |
Onar, Z | 1 |
Kaya, E | 1 |
Cullen, IM | 1 |
Manecksha, RP | 1 |
McCullagh, E | 1 |
Ahmad, S | 1 |
O'Kelly, F | 1 |
Flynn, R | 1 |
McDermott, TE | 1 |
Murphy, P | 1 |
Grainger, R | 1 |
Fennell, JP | 1 |
Thornhill, JA | 1 |
Ladhani, S | 1 |
Gransden, W | 1 |
Tam, VK | 1 |
Kung, WH | 1 |
Li, R | 1 |
Chan, KW | 1 |
Bedenic, B | 1 |
Topic, M | 1 |
Budimir, A | 1 |
Bubonja, M | 1 |
Geroulanos, S | 2 |
Donfried, B | 1 |
Turina, M | 2 |
Peters, HJ | 1 |
Weissbach, L | 1 |
Nuri, M | 1 |
Failla, S | 1 |
Longo, D | 1 |
Fichera, M | 1 |
Oxelbark, S | 1 |
Seufert, RM | 1 |
Germann, G | 1 |
Böttcher, W | 1 |
Ferrie, BG | 1 |
Scott, R | 1 |
Walstad, RA | 1 |
Nilsen, OG | 1 |
Berg, KJ | 1 |
Hart, CA | 1 |
Desmond, AD | 1 |
Percival, A | 1 |
Iversen, P | 1 |
Madsen, PO | 1 |
Leabeater, B | 1 |
Kingston, J | 1 |
Keogh, B | 1 |
Ruddock, G | 1 |
Irwin, J | 1 |
Watson, A | 1 |
Keane, CT | 1 |
Jafusco, F | 1 |
Ansanelli, V | 1 |
Di Lena, C | 1 |
Roberts, AP | 1 |
Phillips, R | 1 |
Griffiths, A | 1 |
Sykes, RB | 1 |
Brouwer, WK | 2 |
Hoogkamp Korstanje, JA | 1 |
Siwińska-Gołebiowska, H | 1 |
Szozda, G | 1 |
Pawluch, D | 1 |
Nowakowska, K | 1 |
Drejewicz, H | 1 |
Wawrzyniak, M | 1 |
Czerwińska, I | 1 |
Kornberg, AE | 1 |
Sherin, K | 1 |
Veiga, P | 1 |
Mydlow, PK | 1 |
Collins, JJ | 1 |
Feld, LG | 1 |
Mauerhan, DR | 1 |
Nelson, CL | 1 |
Smith, DL | 1 |
Fitzgerald, RH | 1 |
Slama, TG | 1 |
Petty, RW | 1 |
Jones, RE | 1 |
Evans, RP | 1 |
Frey, DJ | 1 |
Reichmann, AK | 1 |
Mauch, H | 1 |
Kaiser, D | 1 |
Neidel, F | 1 |
Brumfitt, W | 3 |
Hamilton-Miller, JM | 3 |
Walker, S | 1 |
Markiewicz, K | 1 |
Tatoń, J | 1 |
Trippenbach, T | 1 |
Raźna, I | 1 |
Bierkens, AF | 1 |
Hendrikx, AJ | 1 |
Ezz el Din, KE | 1 |
de la Rosette, JJ | 1 |
Horrevorts, A | 1 |
Doesburg, W | 1 |
Debruyne, FM | 1 |
Chilaka, VN | 1 |
Mayne, CJ | 1 |
Lilley, LL | 1 |
Guanci, R | 1 |
Hvidberg, H | 1 |
Struve, C | 1 |
Krogfelt, KA | 1 |
Christensen, N | 1 |
Rasmussen, SN | 1 |
Frimodt-Møller, N | 1 |
Manka, W | 1 |
Solowiow, R | 1 |
Okrzeja, D | 1 |
Ogle, JW | 1 |
Ohnuma, K | 1 |
Asuka, N | 1 |
Aoyama, R | 1 |
Nagata, K | 1 |
Nakamura, Y | 1 |
Yanagisawa, K | 1 |
Ichihashi, H | 1 |
Tsujimoto, T | 1 |
Yamada, K | 1 |
Yama, H | 1 |
Komaki, K | 1 |
Matsueda, Y | 1 |
Masuko, J | 1 |
Fujii, R | 1 |
Hirama, Y | 1 |
Iwasaki, A | 1 |
Suzuki, H | 1 |
Nakazawa, S | 2 |
Narita, A | 1 |
Niino, K | 1 |
Satoh, H | 1 |
Chikaoka, H | 1 |
Oka, S | 1 |
Hori, M | 1 |
Kono, S | 1 |
Hashimoto, F | 1 |
Toyonaga, Y | 1 |
Kurosu, Y | 1 |
Matsunaga, T | 1 |
Takahashi, T | 1 |
Hotta, M | 1 |
Oikawa, T | 1 |
Sunagawa, K | 1 |
Nanri, S | 1 |
Yamashita, N | 1 |
Akita, H | 1 |
Ichihashi, Y | 1 |
Charton, M | 1 |
Mombet, A | 1 |
Gattegno, B | 1 |
Kalager, T | 1 |
Andersen, BM | 1 |
Bergan, T | 1 |
Brubakk, O | 1 |
Bruun, JN | 1 |
Døskeland, B | 1 |
Hellum, KB | 1 |
Hopen, G | 1 |
von der Lippe, E | 1 |
Rahm, V | 1 |
Wymenga, AB | 1 |
van Horn, JR | 1 |
Theeuwes, A | 1 |
Muytjens, HL | 1 |
Slooff, TJ | 1 |
Slack, RC | 1 |
Castrillón, M | 1 |
Palma, I | 1 |
Azócar, G | 1 |
Tapia, R | 1 |
Silva, A | 1 |
Pescio, S | 1 |
Aguayo, R | 1 |
Triantafilo, V | 1 |
Contreras, J | 1 |
Thompson, L | 1 |
Ridgway, E | 1 |
Stewart, K | 1 |
Rai, G | 1 |
Kelsey, MC | 1 |
Bielawska, C | 1 |
Watanabe, Y | 1 |
Yokota, T | 1 |
Higashi, Y | 1 |
Wakai, Y | 1 |
Mine, Y | 1 |
Bulpitt, D | 1 |
Potter, CE | 1 |
Jaderberg, M | 1 |
Boodt, PJ | 1 |
Snijders, WP | 1 |
Janknegt, R | 1 |
Kauer, FM | 1 |
Wijma, J | 1 |
Manson, WL | 1 |
Eckenhausen, FW | 1 |
Jonker, PL | 1 |
Hoogkamp-Korstanje, JA | 1 |
Kuiper, KM | 1 |
al-Wali, W | 1 |
Knothe, H | 1 |
Friese, S | 2 |
Willems, FT | 2 |
Loriaux, SM | 2 |
Meewis, JM | 1 |
Leigh, DA | 1 |
Joy, GE | 1 |
Tait, S | 1 |
Harris, K | 1 |
Walsh, B | 1 |
Iravani, A | 1 |
Richard, GA | 1 |
Cohen, J | 1 |
Rees, AJ | 1 |
Williams, G | 1 |
Webb, G | 1 |
Robbins, MJ | 1 |
O'Hare, MD | 1 |
Felmingham, D | 1 |
Ridgway, GL | 1 |
Grüneberg, RN | 1 |
Mouquet, C | 1 |
Fusciardi, J | 1 |
Stoupak, MP | 1 |
Vallancien, G | 1 |
Jarlier, V | 1 |
Chatelain, C | 1 |
Grosset, J | 1 |
Viars, P | 1 |
Pricker, GJ | 1 |
Williams, KJ | 1 |
Hebblethwaite, EM | 1 |
Brown, GW | 1 |
Cox, DM | 1 |
Plested, SJ | 1 |
Smith, GW | 1 |
Salvia, G | 1 |
Salmieri, M | 1 |
Alessandria, I | 1 |
Toscano, MA | 1 |
Adams, DH | 1 |
Wood, MJ | 1 |
Farrell, ID | 1 |
Fox, C | 1 |
Ball, AP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Prospective Randomized Trial of Antibiotic Prophylaxis Versus None Before Transperineal MRI-TRUS Fusion Guided Prostate Biopsy[NCT04146142] | 550 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children: a Randomized Controlled Trial[NCT03221504] | 221 participants (Anticipated) | Interventional | 2018-01-01 | Recruiting | |||
Epidemiology of ST131 in Besançon University Hospital[NCT02853708] | 300 participants (Actual) | Observational | 2015-06-30 | Completed | |||
Treatment of Febrile Infectious Disease Among Children in Hadera District Given the Final Diagnosis. Descriptive Study[NCT02313532] | 500 participants (Anticipated) | Observational | 2015-01-31 | Not yet recruiting | |||
Prospective, Randomized Study of the Utilization of Antibiotics and Drains in Spinal Surgery[NCT01608854] | 539 participants (Actual) | Observational | 2008-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for cefuroxime and Urinary Tract Infections
Article | Year |
---|---|
Treatments for symptomatic urinary tract infections during pregnancy.
Topics: Anti-Infective Agents, Urinary; Birth Weight; Cefuroxime; Cephradine; Female; Gestational Age; Human | 2011 |
Renal parenchymal malacoplakia: a rare cause of ARF with a review of recent literature.
Topics: Acute Kidney Injury; Aged; Biopsy, Needle; Cefuroxime; Diagnosis, Differential; Drug Therapy, Combin | 2003 |
Cefuroxime axetil: a new oral cephalosporin.
Topics: Cefuroxime; Cephalosporins; Humans; Prodrugs; Urinary Tract Infections | 1989 |
34 trials available for cefuroxime and Urinary Tract Infections
Article | Year |
---|---|
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial.
Topics: Anti-Bacterial Agents; Biopsy; Cefuroxime; Humans; Male; Prostate; Sepsis; Urinary Tract Infections | 2022 |
7-day compared with 10-day antibiotic treatment for febrile urinary tract infections in children: protocol of a randomised controlled trial.
Topics: Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Double-Blind Method; Drug Administration | 2018 |
Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Female; Fos | 2011 |
Plasma levels of ceftriaxone in cardiovascular surgery.
Topics: Bacterial Infections; Cardiac Surgical Procedures; Cefotaxime; Ceftriaxone; Cefuroxime; Clinical Tri | 1984 |
[Mezlocillin versus cefuroxime in urinary tract infections. A multicenter clinical study].
Topics: Adult; Aged; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Female; Humans; Male; Mezlocillin | 1982 |
[A prospective, randomized comparative study between cefazolin and cefuroxime as perioperative antibiotic prevention in cardiovascular surgery].
Topics: Adolescent; Adult; Aged; Blood Vessel Prosthesis; Cardiovascular Diseases; Cefazolin; Cefuroxime; Ce | 1984 |
[Perioperative antibiotic prophylaxis in elective splenectomy. A randomized prospective study].
Topics: Adult; Cefuroxime; Cephalosporins; Humans; Male; Middle Aged; Pneumonia; Postoperative Complications | 1984 |
Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study.
Topics: Adult; Aged; Bacterial Infections; Cefazolin; Cefuroxime; Cephalosporins; Clinical Trials as Topic; | 1981 |
Single dose ceftriaxone versus single dose cefuroxime plus metronidazole for preventing febrile morbidity and urinary tract infection in vaginal hysterectomy.
Topics: Adult; Aged; Aged, 80 and over; Antitrichomonal Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ent | 1995 |
Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children.
Topics: Administration, Oral; Cefuroxime; Child; Child, Preschool; Colony Count, Microbial; Drug Administrat | 1994 |
Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefazolin; Cefuroxime; Double-Blind Method; Drug Adminis | 1994 |
["Single-shot" antibiotic prophylaxis in thoracic surgery; reduction of the postoperative infection rate].
Topics: Bacterial Infections; Body Temperature; Cefuroxime; Female; Humans; Injections, Intravenous; Leukocy | 1993 |
[Complications in pre- versus intraoperative one-time prophylaxis with cefuroxime after biliary surgery].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefuroxime; Cholecystectomy; Drug Administrati | 1993 |
Enoxacin relieves symptoms of recurrent urinary infections more rapidly than cefuroxime axetil.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Enoxacin; Humans; Middle Aged; Prodrugs; Urinary Tract I | 1993 |
The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Cip | 1997 |
Urinary tract infection prophylaxis in transurethral surgery: oral lomefloxacin versus parenteral cefuroxime.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Cefuroxime; Female; Fluoroquinolones; Humans; Inj | 1992 |
Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety.
Topics: Adult; Aged; Bacteremia; Cefuroxime; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; | 1992 |
Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations.
Topics: Arthritis, Infectious; Arthritis, Rheumatoid; Cefuroxime; Diabetes Complications; Follow-Up Studies; | 1992 |
Definition of urinary tract infection and assessment of efficacy in drug trials--a laboratory perspective.
Topics: Bacteriuria; Cefuroxime; Colony Count, Microbial; Escherichia coli Infections; Female; Humans; Mass | 1992 |
[Treatment of uncomplicated urinary tract infections: cefuroxime vs cotrimoxazole].
Topics: Adolescent; Adult; Aged; Cefuroxime; Female; Humans; Middle Aged; Trimethoprim, Sulfamethoxazole Dru | 1991 |
A large scale, general practice based investigation into the clinical efficacy and tolerability of cefuroxime axetil in women with uncomplicated urinary tract infection.
Topics: Adult; Aged; Cefuroxime; Cystitis; Female; Humans; Middle Aged; Prodrugs; Urinary Tract Infections | 1991 |
Single-dose prophylaxis in hysterectomies. An interim analysis.
Topics: Anti-Bacterial Agents; Cefuroxime; Double-Blind Method; Drug Administration Schedule; Female; Fever; | 1990 |
Vaginal hysterectomy: cefuroxime, metronidazole or both?
Topics: Adult; Aged; Bacterial Infections; Bacteriuria; Body Fluids; Cefuroxime; Double-Blind Method; Drug T | 1990 |
Antibiotic prophylaxis in abdominal hysterectomy, with special reference to the duration of the prophylaxis.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Drug Administration Schedule; Drug Therapy, Combination; F | 1990 |
Antibiotic prophylaxis in vaginal hysterectomy. Three doses of cefuroxime plus metronidazole versus one dose of ciprofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Ciprofloxacin; Drug Administration Schedule; Drug Therap | 1990 |
[Cefuroxime axetil. An antibiotic advances].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Dose-Response Relationsh | 1990 |
Prophylaxis in gynaecological surgery: a prospective randomized comparison between single dose prophylaxis with amoxycillin/clavulanate and the combination of cefuroxime and metronidazole.
Topics: Adult; Amoxicillin; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; | 1989 |
Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
Topics: Acute Disease; Adult; Blood Chemical Analysis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Fem | 1989 |
A prospective randomized controlled trial of perioperative antibiotic prophylaxis in renal transplantation.
Topics: Adult; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Female; Humans; Kidney Transplantation; | 1988 |
[Transurethral surgery and persistent urinary infection: effect of a single preoperative dose of cefuroxime].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Cephalosporins; Electrocoagulation; Female; | 1987 |
Single-dose prophylaxis in gynaecological surgery: amoxycillin/clavulanic acid versus the combination of cefuroxim and metronidazole in a randomized prospective comparison.
Topics: Adult; Aged; Amoxicillin; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therap | 1988 |
Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefur | 1987 |
Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up.
Topics: Amoxicillin; Biological Availability; Cefuroxime; Cephalosporins; Female; Follow-Up Studies; Humans; | 1987 |
[Piperacillin in infections of the urinary tract. Comparison with cefuroxime].
Topics: Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Drug Evaluation; Female; Humans; Male; Middle A | 1986 |
56 other studies available for cefuroxime and Urinary Tract Infections
Article | Year |
---|---|
Antimicrobial resistance trend of bacterial uropathogens at the university of Gondar comprehensive specialized hospital, northwest Ethiopia: A 10 years retrospective study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteria; Ce | 2022 |
Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cefuroxime; C | 2022 |
Compliance to Guidelines in Prescribing Empirical Antibiotics for Individuals with Uncomplicated Urinary Tract Infection in a Primary Health Facility of Ghana, 2019-2021.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Cross-Sectional Studies; Female; Ghana; Hea | 2022 |
BACTERIAL PROFILE, ANTIMICROBIAL RESISTANCE, AND FACTORS ASSOCIATED WITH URINARY TRACT INFECTION AMONG PREGNANT WOMEN AT HOSANNA TOWN HEALTH FACILITIES, CENTRAL ETHIOPIA.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bacteriuria; Cefuroxime; Cephalexin; Cross-Sectional St | 2023 |
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacte | 2020 |
Evaluation of post-flexible cystoscopy urinary tract infection rates.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Col | 2020 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazo | 2017 |
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2017 |
The Escherichia coli phylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cefotaxime; Cefuroxime; Child; Child, Preschool; | 2014 |
Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates.
Topics: Anti-Bacterial Agents; Bacteria; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalothin; Drug Resistance, | 2014 |
An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Base Sequence; Cefuroxime; Drug Resistance, Bacteri | 2014 |
Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Cefuroxime; Ciprofloxacin; Cohort Studies; | 2015 |
Community-acquired urinary tract infection in hospitalized children: etiology and antimicrobial resistance. A comparison between first episode and recurrent infection.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Child, Hospitalized; Child, Preschool; Community-Acqui | 2015 |
Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections.
Topics: Anti-Bacterial Agents; Cefaclor; Ceftriaxone; Cefuroxime; Disk Diffusion Antimicrobial Tests; DNA Gy | 2015 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion | 2015 |
Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Cefuroxime; Community-Acquired Infections; | 2016 |
Factors Associated with Abnormal Imaging and Infection Recurrence after a First Febrile Urinary Tract Infection in Children.
Topics: Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Female; Fever; Humans; Infant; Kidney; Male; Re | 2017 |
Prophylactic antibiotic treatment in severe acute ischemic stroke: the Antimicrobial chemopRrophylaxis for Ischemic STrokE In MaceDonIa-Thrace Study (ARISTEIDIS).
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Female; Humans; | 2016 |
A Relook of Cefuroxime in Community Infections: An Option Still Beneficial.
Topics: Anti-Bacterial Agents; Cefuroxime; Community-Acquired Infections; Humans; Respiratory Tract Infectio | 2016 |
First and recurrent pediatric urinary tract infections: do they have different antibiotic susceptibilities?
Topics: Analysis of Variance; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Drug Resistance, B | 2008 |
Fatal toxic epidermal necrolysis and severe granulocytopenia following therapy with cefuroxime.
Topics: Aged; Agranulocytosis; Anti-Bacterial Agents; Cefuroxime; Fatal Outcome; Female; Humans; Kidney Fail | 2008 |
Kounis syndrome secondary to cefuroxime-axetil use in an octogenarian.
Topics: Aged, 80 and over; Angina, Unstable; Anti-Bacterial Agents; Cefuroxime; Coronary Vasospasm; Diagnosi | 2008 |
Purple urine bag syndrome.
Topics: Aged; Anti-Bacterial Agents; Cefuroxime; Humans; Indican; Klebsiella Infections; Klebsiella pneumoni | 2009 |
[Empirical antibiotic therapy for urinary tract infection in children. Analysis of three hundred patients admitted to a general hospital].
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Female; Humans; Infant; Male | 2010 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; | 2013 |
Increasing antibiotic resistance among urinary tract isolates.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Drug Resistance, Bacterial; Esc | 2003 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; | 2006 |
[Use of cefuroxime in infective pluriorgan pathology. Observations on 60 cases].
Topics: Adolescent; Aged; Bacterial Infections; Biliary Tract Diseases; Cefuroxime; Cephalosporins; Female; | 1984 |
Prophylactic cefuroxime in transurethral resection.
Topics: Adult; Aged; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Evaluation; Humans; Male; Middle | 1984 |
Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency.
Topics: Aged; Cefuroxime; Cephalosporins; Creatinine; Female; Furosemide; Humans; Kidney Diseases; Kinetics; | 1983 |
Treatment of gentamicin-resistant Klebsiella urinary tract infections with cephradine, augmentin, cefuroxime and amikacin.
Topics: Adult; Aged; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephr | 1981 |
Cefuroxime and metronidazole in gynaecological surgery.
Topics: Bacteria; Cefuroxime; Cephalosporins; Female; Genitalia, Female; Humans; Metronidazole; Postoperativ | 1981 |
Treatment of urinary tract infection with cefuroxime in patients with renal failure.
Topics: Adult; Aged; Cefuroxime; Cephalosporins; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; | 1981 |
[Experience with the therapeutic use of cefuroxime in neonatology].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Gastroenteritis; Humans; Infant, Newborn; Infant, | 1981 |
The sensitivity of urinary isolates to cefuroxime, a new beta-lactamase stable cephalosporin.
Topics: Bacteria; Cefuroxime; Cephaloridine; Cephalosporins; Humans; Hydrolysis; Microbial Sensitivity Tests | 1980 |
[Bacterial and clinical evaluation of axetil cefuroxime in suspension].
Topics: Bacterial Infections; Cefuroxime; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial S | 1994 |
[Efficacy and tolerance of axetil cefuroxime for treatment of chronic urinary tract infection relapse in patients with diabetes mellitus].
Topics: Adult; Cefuroxime; Chronic Disease; Diabetic Nephropathies; Female; Humans; Male; Recurrence; Urinar | 1996 |
Postoperative urinary tract infections (UTIs) following single-dose intraoperative antibiotic prophylaxis in colposuspension patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxi | 1998 |
It pays to wait. Cephalosporins and renal insufficiency don't mix.
Topics: Aged; Aged, 80 and over; Aging; Cefuroxime; Cephalosporins; Female; Humans; Nursing Assessment; Rena | 1998 |
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Disease Models, Animal; Dose-Response Relationship, Drug | 2000 |
Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil.
Topics: Adult; Cefuroxime; Cephalosporins; Child Development; Female; Fetus; Follow-Up Studies; Humans; Infa | 2000 |
Antimicrobial therapy for ambulatory pediatrics.
Topics: Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefuroxime; Cephalexin; Cep | 1999 |
[A clinical observation of cefuroxime in pediatric field (author's transl)].
Topics: Adolescent; Bacterial Infections; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Resistan | 1979 |
[Clinical results of cefuroxime (CXM) therapy in pediatric infections (author's transl)].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbia | 1979 |
[Clinico-antimicrobial evaluation of cefuroxime by observation of transitional change of micro-organisms in urine specimen (author's transl)].
Topics: Bacteria; Cefuroxime; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; | 1979 |
[Clinical experience with cefuroxime in pediatric field (author's transl)].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; M | 1979 |
[Fundamental and clinical studies of cefuroxime, a new cephalosporin antibiotic, in pediatric field (author's transl)].
Topics: Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Resistan | 1979 |
[Laboratory and clinical evaluations of cefuroxime in pediatrics (author's transl)].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Administration Sched | 1979 |
[Experience with cefuroxime in pediatric field (author's transl)].
Topics: Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Resistan | 1979 |
The pharmacokinetics of cefuroxime axetil in the sick elderly patient.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cefuroxime; Drug Administration Schedule; Female; Hum | 1991 |
In vitro and in vivo transferrable beta-lactam resistance due to a new plasmid-mediated oxyiminocephalosporinase from a clinical isolate of Proteus mirabilis.
Topics: Animals; beta-Lactamases; Cefuroxime; Cephalosporinase; Cephalosporins; DNA, Bacterial; Drug Resista | 1991 |
Reassessment of cefuroxime axetil for the treatment of recurrent urinary infections.
Topics: Adult; Aged; Cefuroxime; Female; Follow-Up Studies; Humans; Middle Aged; Prodrugs; Recurrence; Table | 1990 |
[One year of Zinnat: effective antibiosis and good tolerance].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Humans; Prodrugs; Resp | 1990 |
Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil.
Topics: Acute Disease; Cefuroxime; Cephalosporins; Female; Humans; Urinary Tract Infections | 1989 |
In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftazidime; Cefuroxime; Gram-Negative Bacteria; Humans; Microbial | 1987 |
Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bacteria; Biological Availability; Cefuroxime; Cephal | 1985 |